meta|IO
Member of the meta|Evidence galaxy
13 trials
23 trials
44 trials
25 trials
1 trials
4 trials
5 trials
14 trials
6 trials
34 trials
17 trials
7 trials
2 trials
3 trials
11 trials
16 trials
8 trials
metastatic/advanced NSCLC (mNSCLC) - 2nd line (L2)
sotorasib
breast cancer - adjuvant
trastuzumab emtasine plus endocrine therapy
everolimus
27 trials
22 trials
15 trials